Facial Plast Surg 2014; 30(01): 026-034
DOI: 10.1055/s-0033-1364220
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Chemical Peels

Adrianna Jackson
1   Advanced Dermatology and Skin Care, Dermatology, Katy, Texas
› Author Affiliations
Further Information

Publication History

Publication Date:
31 January 2014 (online)

Abstract

Chemical peels are a method of resurfacing with a long-standing history of safety in the treatment of various skin conditions. This article reviews the classification of different chemical agents based on their depth of injury. The level of injury facilitates cell turnover, epidermal thickening, skin lightening, and new collagen formation. Preprocedural, periprocedural, and postprocedural skin care are briefly discussed. To select the appropriate chemical peel, the provider should evaluate the patient's expectations, medical history, skin type, and possible complications to determine the best chemical peel to achieve the desired results. Patients with Fitzpatrick skin types IV to VI have increased risk of dyspigmentation, hypertrophic, and keloid scarring. These individuals respond well to superficial and medium-depth chemical peels. Advances in the use of combination peels allow greater options for skin rejuvenation with less risk of complications.

 
  • References

  • 1 Brody HJ, Monheit GD, Resnik SS, Alt TH. A history of chemical peeling. Dermatol Surg 2000; 26 (5) 405-409
  • 2 Lawrence N, Mandy S, Yarborough J, Alt T. History of dermabrasion. Dermatol Surg 2000; 26 (2) 95-101
  • 3 Taylor SC, Badreshia-Bansal S, Callender VD, Gathers RC, Rodriguez DA. Chemical peels. In: Treatments for Skin of Color. Philadelphia, PA: Saunders; 2011: 315-320
  • 4 Tung R, Rubin MG. Procedures in Cosmetic Dermatology Series: Chemical Peels. 2nd ed. Philadelphia, PA: Saunders; 2010
  • 5 Dingman DL, Hartog J, Siemionow M. Simultaneous deep-plane face lift and trichloroacetic acid peel. Plast Reconstr Surg 1994; 93 (1) 86-93 , discussion 94–95
  • 6 Rubenstein R, Roenigk Jr HH, Stegman SJ, Hanke CW. Atypical keloids after dermabrasion of patients taking isotretinoin. J Am Acad Dermatol 1986; 15 (2, Pt 1) 280-285
  • 7 Wolfe SA. Chemical face peeling following therapeutic irradiation. Plast Reconstr Surg 1982; 69 (5) 859-862
  • 8 Monheit GD. The Jessner's-trichloroacetic acid peel. An enhanced medium-depth chemical peel. Dermatol Clin 1995; 13 (2) 277-283
  • 9 Bolognia JL, Jorizzo JL, Rapini RP , et al , eds. Dermatology. 2nd ed. Spain: Mosby; 2008
  • 10 Swinehart JM. Test spots in dermabrasion and chemical peeling. J Dermatol Surg Oncol 1990; 16 (6) 557-563
  • 11 Grimes PE. Aesthetics and Cosmetic Procedure in Darker Racial Ethnic Groups. Philadelphia, PA: Lippincott Williams & Wilkins; 2008
  • 12 Rullan P, Karam AM. Chemical peels for darker skin types. Facial Plast Surg Clin North Am 2010; 18 (1) 111-131
  • 13 Clark III CP. Office-based skin care and superficial peels: the scientific rationale. Plast Reconstr Surg 1999; 104 (3) 854-864 , discussion 865–866
  • 14 Kligman D, Kligman AM. Salicylic acid peels for the treatment of photoaging. Dermatol Surg 1998; 24 (3) 325-328
  • 15 Rubin M. Chemical Peels. Philadelphia, PA: Saunders; 2005
  • 16 Van Scott EJ, Yu RJ. Hyperkeratinization, corneocyte cohesion, and alpha hydroxy acids. J Am Acad Dermatol 1984; 11 (5, Pt 1) 867-879
  • 17 James WD, Berger TG, Elston DM. Andrews' Diseases of the Skin: Clinical Dermatology. Canada: Saunders; 2011
  • 18 Glogau RG, Matarasso SL. Chemical peels. Trichloroacetic acid and phenol. Dermatol Clin 1995; 13 (2) 263-276
  • 19 Koppel RA, Coleman KM, Coleman WP. The efficacy of EMLA versus ELA-Max for pain relief in medium-depth chemical peeling: a clinical and histopathologic evaluation. Dermatol Surg 2000; 26 (1) 61-64
  • 20 Lawrence N, Cox SE, Cockerell CJ, Freeman RG, Cruz Jr PD. A comparison of the efficacy and safety of Jessner's solution and 35% trichloroacetic acid vs 5% fluorouracil in the treatment of widespread facial actinic keratoses. Arch Dermatol 1995; 131 (2) 176-181
  • 21 Hetter GP. An examination of the phenol-croton oil peel: part IV. Face peel results with different concentrations of phenol and croton oil. Plast Reconstr Surg 2000; 105 (3) 1061-1083 , discussion 1084–1087
  • 22 Hetter GP. An examination of the phenol-croton oil peel: Part I. Dissecting the formula. Plast Reconstr Surg 2000; 105 (1) 227-239 , discussion 249–251
  • 23 Wexler MR, Halon DA, Teitelbaum A, Tadjer G, Peled IJ. The prevention of cardiac arrhythmias produced in an animal model by the topical application of a phenol preparation in common use for face peeling. Plast Reconstr Surg 1984; 73 (4) 595-598
  • 24 Beeson WH. The importance of cardiac monitoring in superficial and deep chemical peeling. J Dermatol Surg Oncol 1987; 13 (9) 949-950
  • 25 Alt TH. Occluded Baker-Gordon chemical peel: review and update. J Dermatol Surg Oncol 1989; 15 (9) 980-993